Contact
Please use this form to send email to PR contact of this press release:
U.S. FDA Grants Orphan Drug Designation for ATB200/AT2221 for Pompe Disease
TO:
Please use this form to send email to PR contact of this press release:
U.S. FDA Grants Orphan Drug Designation for ATB200/AT2221 for Pompe Disease
TO: